Daktari Announces Formation of Scientific Advisory Board
Jan 05, 2017 13:01 pm UTC| Business
CAMBRIDGE, Mass., Jan. 05, 2017 -- Daktari Diagnostics, a company focused on making “Anywhere. Care.™” a reality with its portable and ultrasensitive immunoassay-based CarePlatform™, today announced the formation of its...
Wingstop Inc. to Present at the 19th Annual ICR Conference
Jan 05, 2017 13:01 pm UTC| Business
DALLAS, Jan. 05, 2017 -- Wingstop Inc. (“Wingstop” or the “Company”) today announced that it will present at the 19th Annual ICR Conference at the JW Marriott Orlando Grande Lakes in Orlando, FL. The Company will host...
Wingstop Inc. to Present at the 19th Annual ICR Conference
Jan 05, 2017 13:01 pm UTC| Business
DALLAS, Jan. 05, 2017 -- Wingstop Inc. (“Wingstop” or the “Company”) today announced that it will present at the 19th Annual ICR Conference at the JW Marriott Orlando Grande Lakes in Orlando, FL. The Company will host...
Melinta Therapeutics’ New Drug Application for Baxdela Accepted for Filing by US FDA
Jan 05, 2017 13:01 pm UTC| Business
NEW HAVEN, Conn., Jan. 05, 2017 -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, announced today the U.S. Food and Drug Administration (FDA) has...
Melinta Therapeutics’ New Drug Application for Baxdela Accepted for Filing by US FDA
Jan 05, 2017 13:01 pm UTC| Business
NEW HAVEN, Conn., Jan. 05, 2017 -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, announced today the U.S. Food and Drug Administration (FDA) has...
Jan 05, 2017 13:01 pm UTC| Business
SALT LAKE CITY, Jan. 05, 2017 -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced plans to initiate a dosing flexibility (“DF”) study in addition to its previously announced dosing...
Jan 05, 2017 13:01 pm UTC| Business
SALT LAKE CITY, Jan. 05, 2017 -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced plans to initiate a dosing flexibility (“DF”) study in addition to its previously announced dosing...